Prove before claiming
A green build is not proof. Required artefact: test, device, dated capture, or the live protocol above.
See the protocolFrom design to systems
Guillaume Velé
I design, I build, I prove.
Art director and builder in Paris. Medical sites, own media product (Guidechirurgie), systems with replayable proofs, open source. Every claim has a proof, a limit, or an embargo.
Reading shortcuts, or run the protocol.
- Industrial property
- ACUENCE trademark no. 5271632 · patent application under embargo
- Open source
- PyPI, npm, public upstream PR
The jellyfish is a Studio Azur piece. Click in the water: it reacts. Nappe (plankton + hand) is the sequel. Open Azur N3 · swim
Review protocol · live
The page verifies itself.
Your browser queries GitHub, npm and PyPI. A gate replays a refusal. What stays closed is named: embargo, client data, device demo.
01–04 read live. 05 = network ping. Failure = KO, never a fake chip.
Verification log
En attente
Not verified here: measurement method (INPI embargo) · client data · real-device demo on request.
01
github.com/guillaumevele
Public repositories: release gates, quantization, vault tooling, generative work. Every README separates what is proven from what is not. Repo count is read live.
GitHub profile
02
agent-proof-kit
Deterministic gates for agent runs: npx -y -p agent-proof-kit agent-proof verify replays the proof locally, no API key, no network. Published on npm. Version on the live chip.
Repo + npm
03
vibe-fim
Bounded AI code edits via fill-in-the-middle: only the region between two anchors is rewritten, the rest of the file stays byte-identical.
PyPI
04
PR #15 · Q8_0
8-bit quantization of a 4-billion-parameter TTS: hand-written WGSL GPU kernels, Metal and Vulkan. Public upstream PR. Status on the live chip.
Rust · Burn · WebGPU
05
acuence.app
The product site of the skin-reading app (acuence.app): public host reachable from the browser. Full DNS/TLS ownership and infrastructure: outside the live protocol, available on request.
Product · live ping
06
INPI n° 5271632
The ACUENCE trademark, filed on 24 June 2026 with the INPI (classes 9, 42, 44), published in BOPI 2026-29 on 17 July 2026. Official status: application published. The associated patent application stays confidential during review.
Public INPI record
Dated facts (snapshot)
- Patent application filed with the INPI for a skin-reading method. Content confidential while under examination. Embargo
- ACUENCE trademark no. 5271632, BOPI 2026-29, under examination. Verify
- Dated test snapshot: 64/64 agent-proof · 52/52 vibe-fim · 9/9 Compromis, 09 Jul 2026. Current versions: live chips on the cards above. Snapshot
The proof, executing
Real output, recorded on 9 July 2026 against the repo's public fixtures. Replayable: npx -y -p agent-proof-kit agent-proof verify. The third call shows the refusal: the gate fails closed.
Systems
Six systems, six real statuses.
Six files. For each: the status, what can be proven, what stays closed.
iOS · pre-launch · IP filed
Acuence
An iOS skin-reading app. The heart of the product is not the score: it is reading reliability. The app prefers to abstain rather than assert when the signal is insufficient, and that behaviour is tested.
Provable
- Patent application filed with the INPI in June 2026; ACUENCE trademark no. 5271632 (classes 9, 42, 44), published in BOPI 2026-29 on 17 July 2026 and viewable on data.inpi.fr.
- Anti-regression science harness: every PubMed citation is script-verified, a blocking gate runs before any ship.
- Abstention is a first-class state: unreliable measurement means no conclusion is displayed.
- Compliance designed into the copy: no diagnostic language, no dosages, anywhere.
Inspectable
- Product siteacuence.app
- Trademark no. 5271632INPI record
- Measurement methodINPI embargo
- Real-device demoOn request
45science-harness tests
06/2026patent application filed
5271632INPI trademark no.
Tests counted on the repository on 9 July 2026.
Extrait de code
The piece runs live inside this page.
Web · product & clients
Sites.
Own product first (Guidechirurgie: editorial media, SEO, AdSense/Ezoic/affiliate), then client sites: medical, real estate, services. Design, SEO, hosting.
Health media · Own productProduct · monetised
Guidechirurgie
Editorial media built end-to-end: architecture, content, international SEO, monetisation (AdSense, Ezoic, affiliate). Proof a site can rank and fund itself without a services catalogue.
Visit siteBefore AI
Design, first.
Five years of art direction. Identities, campaigns, installations. The eye trained there refuses a fuzzy claim in a product.
Background
From graphic design to systems.
Trained in graphic design (EPSAA, École Estienne). Years of art direction, then building AI products and infrastructure under real conditions.
Today: Guidechirurgie (health media built end-to-end, SEO + AdSense/Ezoic/affiliate), medical client sites in production, a real-estate legal SaaS, a skin-reading iOS app in pre-launch (ACUENCE trademark, patent under examination), and open-source tools on npm and PyPI.
Method: prove before claiming; name embargo and non-public work; retire what does not prove its value.
- Training EPSAA · École Estienne
- Industrial property ACUENCE trademark · patent under embargo
- Public npm · PyPI · upstream PR
- Media Guidechirurgie · monetised
- Base Paris · Île-de-France
Discipline
Four laws of this site.
Not a manifesto: rules already visible in the protocol, the files, and the applied boundaries.
Harness before feature
On Acuence, every PubMed citation is script-verified. A blocking gate runs before any ship.
Acuence fileBoundaries first
INPI embargo, no medical dosages, no client data in public, no risky agent action without confirmation.
Read the closing lineKnow when to retire
Warren, a trading agent, was paper-evaluated then retired. What does not prove its value leaves production.
Hermes fileQuestions
Useful questions.
A few method points, without a pitch.
Who do you work with?
Health structures (sites and SEO), product teams that require design direction and proof, technical reviews of an AI system or a production site.
What is provable here?
Your browser queries GitHub, npm and PyPI. A KO chip is never invented. INPI embargo, client data and device demos stay off-page, and that is stated.
Do you do medical SEO?
Yes: architecture, content, production, follow-up. Institutional tone, no dosages or clinical promises on delivered sites. References are in the Sites section.
How do we continue?
An email to contact@acuence.app with the context and the level of rigour expected. What cannot be public is shown on a call or in person.
Where are you based?
Paris and Île-de-France. Remote work depending on the engagement.
Contact
The rest is shown live.
Real-device demo, infrastructure architecture, full protocols: whatever cannot be published here is shown on a call or in person.
contact@acuence.appGraphic design and systems. One standard: prove before claiming.